vTv Therapeutics Inc. SEC filings VTVT

vTv Therapeutics Inc. has 601 filings in SEC EDGAR's recent list, going back to May 14, 2015. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 10, 2026 Dec 31, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
10-K Annual report Mar 13, 2024 Dec 31, 2023
10-K Annual report Mar 6, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 5, 2022 Dec 31, 2021
10-K Annual report Mar 29, 2022 Dec 31, 2021
10-K Annual report Feb 24, 2021 Dec 31, 2020
10-K Annual report Feb 21, 2020 Dec 31, 2019
10-K Annual report Feb 26, 2019 Dec 31, 2018
10-K Annual report Feb 27, 2018 Dec 31, 2017
10-K/A Amended annual report Jan 16, 2018 Dec 31, 2016
10-K Annual report Feb 24, 2017 Dec 31, 2016
10-K Annual report Mar 4, 2016 Dec 31, 2015

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VTVT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
High Point, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1641489

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.